Animal alternative tests
This article was originally published in The Rose Sheet
Executive Summary
National Toxicology Program is seeking comments and nominations for validation studies of in vitro test methods for identifying endocrine disruptors, agency announces in April 21 Federal Register 1notice. NTP has thus far received two proposals, which were presented by the Interagency Coordinating Committee for the Validation of Alternative Methods at a March meeting of the Scientific Advisory Committee on Alternative Toxicological Methods (2"The Rose Sheet" March 22, 2004, p. 4). ICCVAM will receive comments and nominations and then "develop recommended priorities" for proposed methods, the notice states. In a separate Federal Register 3notice, the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods and ICCVAM report they are seeking nominations for scientific experts to evaluate in vitro test methods for identifying chemicals that potentially cause ocular irritancy...
You may also be interested in...
ICCVAM To Study Alternative Animal Test Feasibility For Ocular Irritation
The Interagency Coordinating Committee on the Validation of Alternative Methods will review four non-animal in vitro tests this year to assess whether they are predictive in identifying severe ocular irritants and corrosives, according to the group
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.